|
Name |
Penochalasin G
|
Molecular Formula | C32H38N2O4 | |
IUPAC Name* |
(1S,6R,7Z,9S,11Z,13S,16S,17R,18S)-6-hydroxy-18-(1H-indol-3-ylmethyl)-7,9,15,16-tetramethyl-19-azatricyclo[11.7.0.01,17]icosa-7,11,14-triene-2,5,20-trione
|
|
SMILES |
C[C@H]/1C/C=C\[C@H]2C=C([C@H]([C@@H]3[C@@]2(C(=O)CCC(=O)[C@@H](/C(=C1)/C)O)C(=O)N[C@H]3CC4=CNC5=CC=CC=C54)C)C
|
|
InChI |
InChI=1S/C32H38N2O4/c1-18-8-7-9-23-15-19(2)21(4)29-26(16-22-17-33-25-11-6-5-10-24(22)25)34-31(38)32(23,29)28(36)13-12-27(35)30(37)20(3)14-18/h5-7,9-11,14-15,17-18,21,23,26,29-30,33,37H,8,12-13,16H2,1-4H3,(H,34,38)/b9-7-,20-14-/t18-,21+,23-,26-,29-,30+,32+/m0/s1
|
|
InChIKey |
TYTBBVIHCPHNMB-DAKFFITJSA-N
|
|
Synonyms |
Penochalasin G
|
|
CAS | NA | |
PubChem CID | 102250704 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 514.7 | ALogp: | 4.0 |
HBD: | 3 | HBA: | 4 |
Rotatable Bonds: | 2 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 99.3 | Aromatic Rings: | 5 |
Heavy Atoms: | 38 | QED Weighted: | 0.377 |
Caco-2 Permeability: | -4.878 | MDCK Permeability: | 0.00001740 |
Pgp-inhibitor: | 0.441 | Pgp-substrate: | 0.988 |
Human Intestinal Absorption (HIA): | 0.013 | 20% Bioavailability (F20%): | 0.883 |
30% Bioavailability (F30%): | 0.075 |
Blood-Brain-Barrier Penetration (BBB): | 0.957 | Plasma Protein Binding (PPB): | 97.83% |
Volume Distribution (VD): | 0.57 | Fu: | 1.68% |
CYP1A2-inhibitor: | 0.275 | CYP1A2-substrate: | 0.537 |
CYP2C19-inhibitor: | 0.948 | CYP2C19-substrate: | 0.666 |
CYP2C9-inhibitor: | 0.874 | CYP2C9-substrate: | 0.551 |
CYP2D6-inhibitor: | 0.498 | CYP2D6-substrate: | 0.762 |
CYP3A4-inhibitor: | 0.974 | CYP3A4-substrate: | 0.356 |
Clearance (CL): | 12.48 | Half-life (T1/2): | 0.523 |
hERG Blockers: | 0.134 | Human Hepatotoxicity (H-HT): | 0.091 |
Drug-inuced Liver Injury (DILI): | 0.223 | AMES Toxicity: | 0.43 |
Rat Oral Acute Toxicity: | 0.839 | Maximum Recommended Daily Dose: | 0.925 |
Skin Sensitization: | 0.598 | Carcinogencity: | 0.549 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.01 |
Respiratory Toxicity: | 0.982 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003856 | 0.826 | D02DMQ | 0.269 | ||||
ENC005215 | 0.812 | D01TSI | 0.265 | ||||
ENC002681 | 0.783 | D0W7WC | 0.260 | ||||
ENC002151 | 0.750 | D0V3ZA | 0.258 | ||||
ENC003586 | 0.748 | D09NNH | 0.258 | ||||
ENC002679 | 0.724 | D0SP3D | 0.251 | ||||
ENC002680 | 0.720 | D00YLW | 0.248 | ||||
ENC002442 | 0.672 | D09ZIO | 0.244 | ||||
ENC002440 | 0.646 | D05EJG | 0.244 | ||||
ENC004447 | 0.646 | D0BV3J | 0.242 |